Experts in the management of Parkinson’s Disease OFF episodes provide insight into the sublingual formulation of apomorphine hydrochloride and discuss differences in its safety and efficacy profiles.
Laxman Bahroo, DO
Advertisement
Associate Professor, Department of Neurology; Director, Botulinum Toxin Clinic; Director, Residency Program, Department of Neurology
Articles by Laxman Bahroo, DO
Key opinion leaders in neurology discuss the safety and efficacy of apomorphine hydrochloride and provide insights into the advantages and disadvantages of its subcutaneous formulation.
Laxman Bahroo, DO and Mindy K. Bixby, DO define OFF episodes in Parkinson’s Disease and discuss how they are often unpredictable and variable in their severity.
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Differentiating Pathologic Features of Alzheimer Disease and Lewy Body Dementia: Charbel Moussa, MBBS, PhD
2
Improving Recognition and Treatment of Hyperkinetic Movement Disorders: Zoltan Mari, MD
3
Donanemab Shows Durable Amyloid Clearance and Consistent Safety in Early-Start Patients
4
Current and Emerging Strategies for Managing Huntington Disease Symptoms: Karen Anderson, MD
5